Prevalence of Amyloid PET Positivity in Dementia Syndromes

Ossenkoppele, Rik; J. Jansen, Willemijn; D. Rabinovici, Gil; L. Knol, Dirk; M. van der Flier, Wiesje; N.M. van Berckel, Bart; Scheltens, Philip; Jelle Visser, Pieter; C.J. Verfaillie, Sander; D. Zwan, Marissa; M. Adriaanse, Sofie; A. Lammertsma, Adriaan; Barkhof, Frederik; J. Jagust, William; L. Miller, Bruce; J. Rosen, Howard; Landau, Susan; L. Villemagne, Victor; C. Rowe, Christopher; Yeob Lee, Dong; L. Na, Duk; Won Seo, Sang; Sarazin, Marie; M. Roe, Catherine; Sabri, Osama; Barthel, Henryk; Koglin, Norman; R. Hodges, John; E. Leyton, Cristian; Vandenberghe, Rik; Van Laere, Koen; Drzezga, Alexander; Förster, Stefan; Grimmer, Timo; Sánchez‐Juan, Pascual; Carril, J.M.; Mok, Vincent; Camus, Vincent; E. Klunk, William; D. Cohen, Ann; T. Meyer, Philipp; Hellwig, Sabine; B. Newberg, Andrew; Steen Frederiksen, Kristian; Fleisher, Adam; A. Mintun, Mark; A. Wolk, David; Nordberg, Agneta; O. Rinne, Juha; Chételat, Gaël; Lleó, Alberto; Blesa, Rafael; Fortea, Juan; Madsen, Karine; M. Rodrigue, Karen; J. Brooks, David

doi:10.1001/jama.2015.4669

Public

Prevalence of Amyloid PET Positivity in Dementia Syndromes

Published in JAMA • May 19, 2015

Authors:

Rik Ossenkoppele

Willemijn J. Jansen

Gil D. Rabinovici

Abstract

IMPORTANCE: Amyloid-β positron emission tomography (PET) imaging allows in vivo detection of fibrillar plaques, a core neuropathological feature of Alzheimer disease (AD). Its diagnostic utility is still unclear because amyloid plaques also occur in patients with non-AD dementia. OBJECTIVE: To use i...

Subject

Medicine

Dementia

Amyloid (mycology)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!